![John Eid](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
John Eid has held the title of Chief Scientific Officer & Director at Pendulum Therapeutics, Inc. since 2012, which is the year he founded the company.
Actieve functies van John Eid
Bedrijven | Functie | Begin |
---|---|---|
Pendulum Therapeutics, Inc.
![]() Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | Oprichter | 01-01-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Pendulum Therapeutics, Inc.
![]() Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | Health Technology |